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Abstract
Differentiation of embryonic stem (ES) cells is accompanied by silencing of the Oct-4 gene and de novo DNA methylation of
its regulatory region. Previous studies have focused on the requirements for promoter region methylation. We therefore
undertook to analyse the progression of DNA methylation of the ,2000 base pair regulatory region of Oct-4 in ES cells that
are wildtype or deficient for key proteins. We find that de novo methylation is initially seeded at two discrete sites, the
proximal enhancer and distal promoter, spreading later to neighboring regions, including the remainder of the promoter.
De novo methyltransferases Dnmt3a and Dnmt3b cooperate in the initial targeted stage of de novo methylation. Efficient
completion of the pattern requires Dnmt3a and Dnmt1, but not Dnmt3b. Methylation of the Oct-4 promoter depends on
the histone H3 lysine 9 methyltransferase G9a, as shown previously, but CpG methylation throughout most of the
regulatory region accumulates even in the absence of G9a. Analysis of the Oct-4 regulatory domain as a whole has allowed
us to detect targeted de novo methylation and to refine our understanding the roles of key protein components in this
process.
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Introduction
Approximately 90% of all CpGs in the mammalian genome are
methylated at the 5 position of the cytosine ring. Specific cell types
and tissues have signature DNA methylation patterns [1–4] that
arise during development in the differentiating cell types [5,6].
Despite the consistency of the methylation patterns in different cell
types and an apparent developmental program for the transition
from one methylation state to another, little is known about the
detailed biological mechanisms by which DNA methylation
patterns are established. Several key proteins that affect this
epigenetic modification are known; most importantly the DNA
methyltransferases, Dnmt1, Dnmt3a and Dnmt3b. Dnmt1 is the
‘‘maintenance methyltransferase’’ that localizes to replication foci
during S phase [7] and copies the DNA methylation pattern to the
newly synthesized daughter strand. Further support to this view
comes from in vitro demonstrations that Dnmt1 preferentially
methylates hemimethylated DNA [8]. Dnmt3a and Dnmt3b, on
the other hand, are de novo methyltransferases, responsible for the
methylation of unmodified DNA. Disruption of all three Dnmt
genes in mouse embryonic stem (ES) cells abolishes CpG
methylation [9] demonstrating that CpG methylation is exclu-
sively dependent on these enzymes. Interestingly, knock-outs of
other protein coding genes, including G9a and Lsh, also reduce
global DNA methylation levels [10,11].
Little is known about the relative contribution of Dnmt3a and
Dnmt3b to de novo methylation patterns. Deletion of the catalytic
activities of either enzyme showed that, at the majority of the
studied loci, methylation was not affected [12]. Only when both
enzymes were depleted could the DNA methylation be erased at
these loci. This suggests that, in most cases, the two enzymes
complement one other. This is further supported by the fact that
Dnmt3a and b associate with one another [13]. There are,
however, differences in specificity, as Dnmt3b alone has been
shown to be responsible for the methylation of centromeric minor
satellite repeats [12], whereas Dnmt3a alone is able to restore the
methylation in the Xist and H19 loci in cells carrying inactivating
mutations in both enzymes [14]. In vitro experiments have not
revealed intrinsic sequence specificities of the Dnmt3 enzymes and
more in vivo studies are needed to dissect the roles of the two
proteins in de novo methylation of individual genes.
It seems likely that local DNA methylation patterns arise not
from an intrinsic specificity of Dnmts themselves, but via
interactions with other DNA binding proteins. Transcription
factors in particular are known to display DNA sequence
specificity and Dnmts have been reported to associate with E2F-
Rb [15], GCNF [16], COUP-TF1[17], PML-RAR [18] and
RP58 [19]. Dependence of DNA methylation on histone
modifications has been clearly demonstrated in fungi and plants
[20–23], but in animals this link is less robust. Nevertheless, there
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e9937is evidence that the histone H3 lysine 9 methylatransferase G9a
can recruit Dnmts to the Oct-4 locus and other loci upon ES cell
differentiation [10].
Local exclusion of DNA methylation represents another general
mechanism for determining patterns of DNA methylation and this
can also depend on transcription factor binding. The non-
methylated status of the CpG island at the rodent aprt gene, for
example, depends on the presence of Sp1 binding sites in the
promoter of the gene [24–26], although the mechanism of
protection is unknown. Evidence for similar prevention of DNA
methylation has also been uncovered at the imprinted H19/Igfr2r
locus [27]. In that study, binding of the CTCF factor to the
differentially methylated region (DMR) of the maternal allele
appeared to prevent methylation and regulate enhancer activity in
cis.
In this study we revisit the in vitro differentiation of embryonic
stem (ES) cells in order to study the establishment of DNA
methylation in the upstream regulatory region of the Oct-4 gene.
Previous high-resolution studies have focused on the de novo
methylation of the promoter region of Oct-4 [28–32], but have not
analyzed parameters that influence methylation of the 2000 base
pair upstream region that has been implicated in the differential
regulation of Oct-4 gene expression in ES cells and the epiblast
[33]. We therefore decided to establish the detailed dynamics of
methylation at all known regulatory elements of the gene using
both wildtype and mutant ES cell lines. Our findings uncover
targeted de novo methylation followed by spreading throughout the
region. In addition, we detect differential roles for Dnmt3a and
Dnmt3b in the spreading phase and implicate Dnmt1 and Lsh in
this process. Finally, we find that the histone H3K9 methyltrans-
ferase G9a is dispensable for methylation of much of the Oct4
regulatory region.
Results
DNA methylation is initiated at discrete regions of the
Oct-4 regulatory region
Three regulatory elements, corresponding to the promoter, the
proximal enhancer and the distal enhancer, have been identified
in the 2Kb region upstream of the transcription start site of Oct-4
(Figure 1A) [33–35]. In order to dissect the establishment of
methylation in the upstream region of the gene, mouse ES cells
were differentiated in vitro for nine days: LIF was removed from the
medium on day 1 and, 3 days later, retinoic acid (RA) was added
for up to 6 days. Cells were harvested at the following stages:
undifferentiated ES cells (ES), embryoid bodies after 3 days of
differentiation (EB3), differentiating cells after 2, 4 or 6 days of
treatment with retinoic acid (RA2, RA4 and RA6) for mRNA and
DNA methylation analysis (Figure 1B). In accordance with
previous studies of a subset of CpGs in the 2 Kb upstream region
of the gene [30], the methylation levels of the entire 2 Kb
upstream regulatory region of Oct-4 in our experimental system
increased only after transcription of the gene had been silenced
(Figure 1C). Inspection of the detailed methylation profile of the
region confirmed that no CpG position had accumulated
appreciable methylation levels before the RA2 stage (Figure 2),
by which point the gene was virtually silent. These findings
confirm that DNA methylation is not responsible for the primary
silencing event at this gene.
We wanted to know if the DNA methyltransferases respon-
sible for the observed methylation of the Oct-4 locus upon in vitro
differentiation were preferentially targeted to specific sites
within this domain or if the process stochastically affected all
CpGs equally. In the first case we should be able to observe
distinct methylation foci, while in the second, methylation
should uniformly increase throughout the examined region. We
divided the 2 kb upstream region in seven segments (Figure 2,
top), four of which overlapped the known regulatory elements of
Oct-4: the distal enhancer (DE); the proximal enhancer (PE), and
the distal and proximal regions of the promoter (DP and PP). In
addition, we analysed three intergenic regions with no known
regulatory function (I1, I2 and I3). Although the entire
promoter region has promoter activity in reporter assays [33],
only the proximal portion contains known transcription factor
response elements, anchors of the basal transcription machinery
and is conserved in mammals [34]. Altogether our analysis
includes all 34 CpG sites within 2057 bp upstream of the
transcription start site.
Two days after addition of RA (RA2), DNA methylation
became detectable at the proximal enhancer and distal promoter
regions (Figure 3). Methylation in these regions continued to
increase at RA4, while the distal enhancer and proximal promoter
regions appeared comparatively resistant to methylation by
comparison. Preferential appearance of methylation peaks at PE
and DP was confirmed in independent experiments (Figure S1A-
B), while the absence of any corresponding peak in a random in
silico-generated methylation pattern, matching the experimental
data for the number of CpGs and the number of clones sequenced
per segment, showed that the observed pattern is unlikely to be an
artifact of the experimental design (Figure S1C). By the end of the
differentiation process (RA6), methylation was high throughout
the region, although the DE and PP continued to have
significantly lower methylation levels. A similar pattern to RA6
was revealed when DNA from adult mouse tail tips were analyzed
(Figure S1D), indicating that RA6 successfully captured the end-
point of the methylation process. As an independent method of
assessing DNA methylation we performed COBRA analyses at the
distal promoter region of Oct-4. This agreed with the methylation
levels as measured by bisulfite sequencing (Figure S2).
Dnmt3a, Dnmt3b and Dnmt1 have overlapping but
distinct roles in the establishment of the methylation
pattern
Our data show that DNA methylation is initially targeted to the
proximal enhancer and distal promoter elements of the Oct-4
promoter. To assess the specific contribution of each Dnmt in the
establishment of the methylation pattern, we repeated the in vitro
differentiation process (Figure 1B) with ES cells that were null for
Dnmt3a, Dnmt3b, both Dnmt3a and Dnmt3b,o rDnmt1. Although
these cells have been reported to be defective in the differentiation
process [36],we found that the silencing of the Oct-4 gene under
the influence of retinoic acid in both Dnmt1 and Dnmt3a/b mutants
followed kinetics that were indistinguishable from wildtype ES cells
(Figure S3 B-C). We therefore consider that the differentiation
defects of these mutants do not affect to the events that accompany
Oct-4 silencing.
In the absence of Dnmt3a (Figure 3B), which was previously
shown to be enriched in the promoter of Oct-4 upon differentiation
[31], the initial phase of de novo methylation appeared relatively
normal, a pronounced peak appearing at PE. As differentiation
progressed, however, the cells were unable to maintain the
methylation pattern and by the end of the differentiation process
the overall methylation level was low and distributed across the
region. Especially for the PE we observed a drop of the
methylation levels between RA2 and RA4 that cannot be
explained by passive demethylation of the locus. A possible
explanation is that there has been some random clonal selection
on the population of differentiating ES cells. These results indicate
Targeting of DNA Methylation
PLoS ONE | www.plosone.org 2 April 2010 | Volume 5 | Issue 4 | e9937Figure 1. Acquisition of DNA methylation within the upstream regulatory region of the mouse Oct-4 gene. A) Schematic diagram of the
Oct-4 upstream regulatory region. B) Outline of the protocol for ES cell in vitro differentiation. C) Expression and methylation profiling of Oct-4 during
in vitro differentiation of wildtype ES cells. The expression is the average of four independent experiments and the error bars show 6 the standard
error of the mean. Methylation values are the average for the entire upstream region (see detailed bisulfite results in Figure 2).
doi:10.1371/journal.pone.0009937.g001
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cannot alone complete the process. Absence of Dnmt3b, on the
other hand, had no significant effect on the methylation pattern
and preserved the preferential methylation of PE and DP, as in the
wildtype cells (Figure 3C). We conclude that although Dnmt3b may
contribute to the initiation of methylation at the locus, it is not
essential for this process.
The Dnmt3a/3b double knock-out cell line (Figure 3D) had
a more severe methylation phenotype than the Dnmt3a KO,
as initiation of methylation at PE and DP was not seen and low
methylation levels did not change markedly during differentiation.
The initiation and spreading of DNA methylation at the Oct-4
regulatory region is therefore dependent on de novo methyltrans-
ferases and cannot be achieved by the ‘‘maintenance’’ enzyme
Dnmt1 alone. Deletion of Dnmt1 is incompatible with differenti-
ation and reduces the global DNA methylation levels to about
20% of wildtype [36]. Nevertheless, a prominent peak
of methylation was present at PE in these cells (Figure 3E). Thus
in the presence of Dnmt3a and 3b alone, the proximal enhancer
remains a target for de novo methylation. For this to spread
to other parts of the regulatory region, however, Dnmt1 is
required.
G9a is important for the establishment of the
methylation pattern but not for the recruitment of
Dnmts
It has been reported that DNA methylation at the Oct-4
promoter is dependent on recruitment of the histone H3 lysine 9
methyltransferase G9a. We therefore asked whether the same G9a
dependence applied to the entire regulatory region of Oct-4
(Figure 3F). Quantitative expression analysis confirmed that Oct-4
expression declines during differentiation, as in wildtype ES cells
(Figure S3D). We confirmed the previous finding that promoter
methylation is minimal in G9a-null ES cells [31], as methylation at
RA6 was present at only about 5% of CpGs in PP and DP.
Unexpectedly, extensive de novo methylation accrued elsewhere
in the regulatory region as these mutant cells differentiated. The
overall level of methylation across the examined domain reached
,20% of CpGs by RA6 compared with ,40% in wildtype cells.
Figure 2. Time-course of DNA methylation across the upstream regulatory region of Oct-4 during in vitro differentiation. Convergent
arrowheads indicate the position of the primer pairs and solid lines the segments analysed. Each differentiation stage is indicated at the left with the
corresponding methylation data to its right. Empty and filled circles denote unmethylated and methylated CpGs, respectively. Each horizontal row of
circles represents one sequenced DNA clone. The single asterisked CpG indicates the HpyCh4 IV recognition site and the double asterisked CpG
indicates the RARE that is always protected (see text).
doi:10.1371/journal.pone.0009937.g002
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PLoS ONE | www.plosone.org 4 April 2010 | Volume 5 | Issue 4 | e9937Figure 3. Altered DNA methylation in differentiating ES cells lacking proteins implicated in de novo methylation. The y-axis shows the
ratio of methylated CpGs versus all CpGs in each segment. The differentiation stages are shown above each column and genotypes are indicated on
the left. ND, not determined. The error bars show the standard error of the mean and asterisks denote the p-value calculated using the Exact
Wilcoxon test. Only significant values according to the Wilcoxon permutation test are shown using the following convention: *, p,0.05; **, p,0.01;
***, p,0.001. Similar trends in pairwise statistical significance were summarized by asterisks above a single bar. In these cases only the lowest p value
of all pairwise comparisons is shown. A detailed list of the pairwise comparisons that have been summarized in this figure is found in the Text S1.
doi:10.1371/journal.pone.0009937.g003
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wildtype Oct-4 methylation pattern, but significant levels of
methylation do accumulate in its complete absence.
Lsh improves coordinated methylation of neighbouring
CpGs
Mammalian Lsh is closely related to the Arabidopsis protein
DDM1 and mutations in both genes cause hypomethylation of the
genome [37,38]. Lsh belongs to the SNF2 family of chromatin-
remodeling ATPases and has been shown to interact with Dnmt1,
Dnmt3a and Dnmt3b [11,39]. Lsh has been reported to play a
role in the establishment of methylation in at least one CpG in the
promoter of Oct-4 (HpyCH4 IV site, see asterisk in Figure 2) [11].
We therefore sought to analyze in detail the effect of Lsh
deficiency on the establishment of DNA methylation throughout
the upstream regulatory region of Oct-4. For this, we created stable
ES cell lines containing the siRNA construct for Lsh used in
previous studies [11] and after identification of the successful
knock-downs (Figure 4A), we differentiated them as described in
Figure 1B. In agreement with previous results [11], at RA6 we
observed a moderate reduction in the methylation levels at the
HpyCh4 IV site (52% in the siRNA relative to 83% in scramble).
Analysis of the bisulfite results segment-by-segment, however,
showed that the effect of the Lsh depletion on DNA methylation
levels and the overall methylation pattern was minimal (Figure 4B).
Closer examination did however reveal a difference in the
coherence of DNA methylation at adjacent CpG sites (Figure
S4). As a measure of variability, we calculated the standard
deviations of the methylation levels of each pair of neighboring
CpGs in the Oct-4 upstream region for the cells treated with siRNA
and a scrambled sequence control. An additional control was
generated in silico as a randomized methylation pattern matched
for the number of clones sequenced and number of sequencing
amplicons in the experiment. As Figure 4B shows, the RA6 sample
with downregulated Lsh had significantly less coordination of
DNA methylation between adjacent sites than did the scrambled
siRNA samples or the randomly generated control pattern.
Moreover, this result was specific to Lsh knockdown, as it was
not reproduced in RA6 samples from Dnmt3b-null cells (Figure 4C,
right panel). A possible interpretation of our data is t that the
motor function of Lsh contributes to the processivity of de novo
methylation by insuring that modification of a CpG site leads to
modification also at adjacent CpGs in the genomic DNA
sequence.
Discussion
Despite the undisputed importance of DNA methylation
establishment in mammalian development, little is known about
the mechanism that targets specific loci in the genome in a timely
and coordinated manner. A key reason for our ignorance has been
the scarcity of known genomic loci that reproducibly acquire DNA
methylation within a defined timeframe. An exception is the Oct-4
gene, which has been the subject of several studies. We decided to
re-visit this system in order to extend the analysis to all CpG sites
within the 2000 bp regulatory region that drives regulated
expression of this gene. This region contains the three regulatory
elements (the promoter, the proximal enhancer and the distal
enhancer) that have been shown to regulate Oct-4 expression in vivo
[35].Our findings confirmed that DNA methylation of the region
follows silencing of the Oct-4 gene. We also verified that the
histone methyltransferase G9a is required for appropriate
methylation of the promoter region, but the data show that
methylation of most of the region is not G9a-dependent. The
proposed central role of G9a in transcriptional shut down at this
locus deserves reassessment in the light of these data.
We detected a distinctive methylation pattern during the early
stages of establishment of DNA methylation at the upstream
regulatory region of the Oct-4 gene. The proximal enhancer and,
to a lesser extent, the distal portion of the promoter are the
primary targets for methylation, which subsequently spreads and
accumulates throughout the region. The distal enhancer and the
proximal promoter, however, maintain significantly lower meth-
ylation levels throughout, suggesting that they represent the
boundaries of the DNA methylation domain. An important
implication of this observation is that the Dnmts responsible for
methylating this region do not attack the silenced gene at random
but are targeted to specific locations. A previous study of de novo
methylation at the human P16 gene in primary mammary
epithelial cell lines inferred site-specific initiation of de novo
methylation followed by spreading to intervening regions [40].
The mechanism of targeting to DP and PE is not known, but a
simple possibility is that the enzymes are actively recruited to these
sites once silencing has occurred. Supporting this model, the
transcriptional activator LRH-1 is released from the early-
methylated PE upon differentiation as part of the gene-silencing
process [41]. We also note that the retinoic acid response element
(RARE) in the promoter (double-asterisk Figure 2) is the anchoring
site for both the Oct-4 activator SF-1 and the repressor GCNF
[42]. This CpG site is therefore expected to be protected whether
the gene is active or inactive, which may explain why it is always
hypo-methylated relative to surrounding CpGs in this (Figure 3A)
and other [30] studies. The repressor GCNF has been implicated
in active recruitment of Dnmts. Co-immunoprecipitation assays
showed interaction with Dnmt3a and Dnmt3b [30] and
overexpression of either GCNF alone, or GCNF plus Dnmt3a,
increased the methylation levels of DP. In the absence of GCNF
there is virtually no methylation at the I3, DP and PP regions upon
differentiation of ES cells [28]. Taken together, these results
suggest a mechanism whereby specific recruitment of Dnmts and
accessibility to specific DNA sequences combine to generate the
methylation pattern identified in this study.
We analyzed the specific contribution of each Dnmt to the
methylation pattern by using mutant ES cell lines. Although these
experiments demonstrated redundancy in the activity of Dnmt3a
and Dnmt3b as regards initiation of de novo methylation, on the
Oct-4 upstream regulatory region, they indicated that Dnmt3a
plays a dominant role over Dnmt3b during the spreading phase. In
the absence of Dnmt3b, the level of methylation in the Oct-4
regulatory region was minimal after 6 days treatment with retinoic
acid. A previous study also showed a more severe effect in the
methylation of the promoter and I3 regions of the Oct-4 gene in
the absence of Dnmt3a than Dnmt3b [29]. In the same study
however, absence of DNMT3b had an appreciable effect on the
methylation levels, which nevertheless varied depending on the
examined cell type. Examination of the 2 kb upstream regulatory
region in the Dnmt3a/b double knockout cell line also suggested a
role of Dnmt1 in spreading, as the accumulation of DNA
methylation outside PE and DP was negligible during days 2 to
6 of retinoic acid treatment in Dnmt1-deficient cells. Others have
observed that the Oct-4 promoter in Dnmt1-/- fibroblasts is less
methylated than in wild-type [31]. Although Dnmt1 is regarded as
having exclusively maintenance methyltransferase activity, previ-
ous studies have shown it can cooperate with Dnmt3a for de novo
methylation of both naked [43] and nucleosomal [44] DNA.
Furthermore, Dnmt3 proteins co-immunoprecipitate with Dnmt1
[13,45]. Our results support an active role of Dnmt1 for de novo
methylation pattern establishment.
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sensitive restriction sites in the promoter of Oct-4 have suggested a
targeting role for the H3K9 methyltransferase G9a in recruiting
Dnmts to Oct-4 [31]. Our bisulfite results support the conclusion
that G9a is essential for full methylation of the promoter, in
agreement with previously published bisulfite data on the
Figure 4. Nearest neighbour DNA methylation analysis reveals a defect in Lsh-deficient ES cells. (A) Western blot of the parental wt ES
cell line, as well as the scramble and Lsh KD cell lines used in this study. TOP: anti-LSH antibody, BOTTOM: loading control, anti-HDAC2 antibody (B)
DNA methylation levels in each segment of the Oct-4 regulatory region in cells harboring the specific construct against Lsh (siRNA) or a scrambled
control (scramble). The RA6 time point was analyzed. Annotation is as Figure 3. The asterisks above DP in both bar plots are against all other
segments. (C) Box plots of the standard deviations of the methylation levels of neighboring CpGs. The statistical analysis was performed with the
Wilcoxon test.
doi:10.1371/journal.pone.0009937.g004
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elsewhere within the 2 kb regulatory region can be established in
the absence of G9a. Accumulation of methylation to wildtype
levels is, however, incomplete in differentiating G9a-null cells,
suggesting that the presence of G9a facilitates full methylation in
this region.
The effect of Lsh depletion on overall DNA methylation levels
in the Oct-4 regulatory region was negligible, but we found that
the correlation between levels of methylation at adjacent CpG sites
was significantly reduced. It should be noted that there were
residual levels of Lsh in the stable KD cell lines, which could
explain the subtlety of the observed phenotype. A potential
explanation for this effect is that Lsh contributes to the
cooperativity of DNA methylation spreading. When Lsh is
depleted, CpG site methylation appears to be more stochastic as
sites are methylated independently of the methylation status of
their neighbors. As Lsh is related to ATP-dependent motor
proteins, it is conceivable that it facilitates mobilization of Dnmts
within this region of the genome. Consistent with this possibility,
Lsh has been shown to interact with Dnmt1, Dnmt3a and Dnmt3b
[11,39]. The reduced genome-wide methylation observed in Lsh
KO cells and tissues [38] may be explained by failure of Dnmt
mobilization. Similarly, the residual methylation observed in the
I2-I3 regions upon differentiation of Lsh knock-down EC cells
[46], could also be explained by this mechanism. It has been
shown that Lsh -/- Day 18.5 embryos have an 8-fold reduction in
the methylation of the I1, PE and promoter regions of the Oct-4
gene, which could be the result of long-term lack of Dnmt
mobilization or Dnmt stability on the locus [46].
Overall, our results suggest that the Oct-4 regulatory region is
best viewed as an extended DNA methylation domain whose de
novo DNA methylation during differentiation occurs in two
phases: initiation of methylation preferentially at specific sites,
followed by spreading of methylation throughout the domain.
Progression through these phases requires the collaboration of
several proteins in addition to the de novo and maintenance Dnmts.
Analysis of the kinetics and factor-dependency of epigenetic
changes across the entire domain may permit a better under-
standing of the mechanisms underlying de novo methylation in
general.
Materials And Methods
Cell lines and cell culture
The wt ES cell line used in the study was the E14Tg2a [47].
The Dnmt3a, Dnmt3b Dnmt3a/b knockout cell lines [12] and the
Dnmt1
S KO cell line [48] are were gifts from Dr En Li. The G9a
KO cell line is the 2–3 clone described in [49].
For the creation of stable knocked-down Lsh ES cell lines, the
E14Tg2a ES cells were transfected with the siRNA plasmid [11]
using Lipofectamine 2000 (Invitrogen). The cells were then plated
at low densities and the successful transfections were selected with
G418 for ten days. Single-cell colonies were picked and expanded
under continuing G418 selection.
ES cells were grown on precoated gelatinized flasks at 37uCi n
the presence of 5% CO2 in 1x Glasgow modified Eagle’s Medium
(Invitrogen) supplemented with 1 mM sodium pyruvate (Invitro-
gen), 1x non-essential amino acids (Invitrogen), 10% foetal bovine
serum (HyClone), LIF and 1:1000 b-mercaptoethanol (Invitrogen).
For in vitro differentiation, one T75 flask of confluent ES cells
was transferred to a 100 mm
2 bacteriological Petri dish with full
medium without LIF and incubated at 37uCi n5 %C O 2 for three
days. Then a 1:10,000 dilution of RA stock solution (Sigma) was
added to the full medium without LIF and the cells were harvested
after 2, 4 or 6 days. The differentiation medium was changed
every two days and the developing embryoid bodies were handled
with wide-orifice serological pipettes. The RA was added fresh in
the medium each time.
Bisulfite genomic sequencing and COBRA
2 mg genomic DNA were digested with Kpn I (NEB) and treated
with sodium bisulfite as described [50]. The treated DNA was then
PCR amplified with the following primers: DP&PP: oct fw (2208)
59-TTTGAAGGTTGAAAATGAAGTTTT-39, oct rev(+55) 59-
CAACCATAAAAAAAATAAACACCCC-39; I3: oct fw(2485)
59-GTTGTTTTGTTTTGGTTTTGGATAT-39, oct rev(2235)
59-AATCCTCTCACCCCTACCTTAAAT-39; I2: oct fw(2848)
59- AGGTTTTTTTGATTTGAAGTAGA-39, oct rev(2535) 59-
AACTCTACACCATAAAACCCC-39; PE: oct fw (21199),
59-AGGGTAGGTTT TTGTATTTTTTTT-39, oct rev(2983)
59-ACTCCCCTAAAAACAACTTCCTACT-39; I1: oct fw
(21670) 59-GTGTTATGTGTAGTTGTGTGTAGGT-39, oct
rev(21341) 59-TTATCTATCTACTCCTACACCATACT-39;
DE: oct fw (22088) 59-GGTTTTAGAGGTTGGTTTTGGG-
39, oct rev(21749) 59-CATCTCTCTAACCCTCTCCATAA-
ATC-39. The PCR reactions were performed with the FastTaq
from Roche. The cycling conditions were: 1 minute at 92uC,
followed by 35 cycles of 30 seconds denaturation at 92uC, annealing
for 30 seconds and elongation at 72uC for 30 seconds. The exact
annealing temperatures for each primer pair were: DP&PP: 63uC,
I3: 58uC, I2: 60uC, PE:6 0 uC, I1: 60uCa n dDE: 63uC. The PCR
products were cloned and approximately 8–30 clones were
sequenced for each amplicon. To avoid clonal amplification of
the sequences, the transfected cells were not incubated before
plating.
Analysis of the sequenced results was performed with the
software BiQ Analyser [51]. In brief, the original genomic
sequence was aligned with the sequenced clones and the quality
of the sequences was assessed. The efficiency of the bisulfite
conversion was judged by the absence of non-converted cytosines
in a non-CpG context and clones with conversion rates below 90%
were removed. Similarly, clones that shared homology with the
genomic sequence below 80% or, in rare cases, that had identical
(probably clonal) methylation patterns were removed from the
analysis. The only exception was the specific case of homoge-
neously methylated or homogeneously unmethylated clones,
which were included in the results.
For the COBRA experiments [52], the bisulfite-treated DNA
was amplified as before using the the oct fw (2208) and oct
rev(+55) primers. The amplicons were then gel-purified using the
QIAquick Gel Extraction Kit (QIAGEN). Purified DNA (10 ng)
was digested with HpyCH4 IV (NEB) according to the
manufacturer’s instruction. The digestion products were resolved
in either a 3% agarose gel or a 6% native acrylamide gel and
visualized with SYBRGold (Molecular Probes). The gel was
scanned in a STORM imaging system (GE Healthcare) at 100 mm
resolution. The quantification of the digestion products was
performed using the Image J software (http://rsb.info.nih.gov/ij/).
Statistical methods
All statistical analyses were performed with the R programming
language. The methylation levels per segment were calculated by
averaging the methylation of all CpGs and all clones for each
segment.
To assess the significance of the differences in methylation
between segments, the exact Wilcoxon test and the Wilcoxon
permutation test was performed using the package ExactRankT-
ests. For these tests the methylation data for each time point were
Targeting of DNA Methylation
PLoS ONE | www.plosone.org 8 April 2010 | Volume 5 | Issue 4 | e9937organized in tables were columns represented segments and rows
the sequenced clones. The tests were subsequently performed for
pairs of columns. Only the comparisons that passed both tests were
characterized as significant.
For assessing the pairwise standard deviations of neighboring
CpGs in the Lsh KD and controls, first the average methylation of
each CpG was calculated from all clones and then the standard
deviations were determined. The significance of the different
distributions of the standard deviations was assessed with the
Wilcoxon test.
The randomized in silico data in all cases were obtained by
generating random deviates for the distribution of the Wilcoxon
Signed Rank statistic obtained from a sample with size n repeated
x times, where x is the number of CpGs contained in the segment.
Supporting Information
Figure S1 Analysis of the methylation profile per segment of the
Oct-4 upstream regulatory region in two independent differenti-
ation experiments using WT ES cells (A and B), tail tip DNA (D)
or an in silico randomly generated methylation pattern (C).
Found at: doi:10.1371/journal.pone.0009937.s001 (0.07 MB
PDF)
Figure S2 COBRA validation of the bisulfite sequencing results.
(A) Position of the HpyCH4 IV diagnostic site in the bisulfite-
converted P amplicon. The upper (purple) sequence represents the
result of bisulfite when all the CpGs (blue) in the original DNA are
methylated. The preserved HpyCH4 IV site is shown in a red box
(also see Figure 2,asterisc). The lower (green) sequence has been
derived assuming all the CpGs in the original DNA are
unmethylated. Note that in this case the HpyCH4 IV site is lost.
(B) Representative image of a COBRA experiment. The 210bp
fragment has been derived from a methylated CpG in the original
sequence while the undigested 270bp fragment indicates lack of
methylation. U:unmethylated, M:methylated, L:DNA molecular
weight ladder. (C) Quantification of the results from the COBRA
experiments (triplicate). The data are juxtaposed with the %
methylation of the specific CpG site as measured by bisulfite
sequencing. The error bars show the standard error of the mean.
Found at: doi:10.1371/journal.pone.0009937.s002 (0.17 MB
PDF)
Figure S3 Shutdown of Oct-4 relative to Gapdh during in vitro
differentiation of KO ES cells.(A) Wildtype cells, the same as in
Figure 1C. (B) Dnmt1 KO cells, one experiment. (C) Dnmt3a/b
DKO cells, the average of two independent experiments. (D) G9a
KO cells, the average of three independent experiments; the error
bars are the standard error of the mean in all cases.
Found at: doi:10.1371/journal.pone.0009937.s003 (0.15 MB
PDF)
Figure S4 Methylation of neighboring CpGs is less coordinated
in Lsh knockdown cells than in controls. The panel shows raw
methylation data of Lsh KD RA6 cells (red) compared with
controls transfected with scrambled siRNA (blue).
Found at: doi:10.1371/journal.pone.0009937.s004 (0.16 MB TIF)
Text S1 Supplementary Legend to Figure 3.
Found at: doi:10.1371/journal.pone.0009937.s005 (0.03 MB
RTF)
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